Johnson & Johnson

FDA Wants Tougher Warnings On TNF-Inhibitors

2 Comments

Director Of Controversial TMAP Program Leaves

5 Comments

Hearty News From Europe’s Cardiology Meeting

Make a comment

Up And Down The Ladder… Job Changes

Make a comment

Pharmalot… Pharmalittle… A Holiday Weekend

Make a comment

More Pharma Job Losses At UCB And J&J

Make a comment

Amgen Ends Some Aranesp Pricing Practices

Make a comment

Pharmalot… Pharmalittle… Morning Edition

Make a comment

FDA Wants More Info On J&J Drug For Pneumonia

Make a comment

Clinical Trials In India And 49 Infant Deaths

Make a comment

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/